硫酸盐治疗性症:治疗的最佳持续时间有没有?
Julia Vaz1, Eduardo Rosa2, Luciene Magalhães3
1Nephrology Division, Medical School, Universidade de São Paulo, São Paulo, Brazil.
概括
罕见的血管疾病 - - 石灰症可以用硫酸硫酸治疗. 这项案例研究表明,在慢性病患者的2年治疗后,细胞控制得到改善.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 皮肤病学 皮肤病学
- 血管生物学 血管生物学
背景情况:
- 石灰是一种罕见的,严重的疾病,涉及微血管化和闭塞.
- 关键的危险因素包括慢性病 (CKD) 和二次性副甲状腺功能障碍症.
- 诊断是临床的;治疗缺乏随机对照试验,依靠专家意见.
研究的目的:
- 报告慢性脏病患者长期治疗状的情况.
- 为了评估硫酸盐与外科手术相关的疗效.
主要方法:
- 一个病例报告,一个患有慢性病的病人正在接受血液透析.
- 治疗涉及2年硫酸盐的管理.
- 手术管理包括脱bridement和重建性整形手术.
主要成果:
- 患者对延长的硫酸治疗反应良好.
- 通过综合治疗方法实现了疾病控制.
- 多学科管理导致了积极的患者结果.
结论:
- 长期的硫酸盐治疗可以对化症有益.
- 医疗和手术干预的组合是有效的管理calciphylaxis.
- 这个案例突出了复杂疾病的成功治疗策略.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Tonsillitis II: Management
103
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
103
Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119


